Can the DHB please advise how many courses of the following Covid-19 treatments have been dispensed to both inpatients and outpatients between January 1 and April 28:
o Baricitinib (Olumiant)
o Casirivimab with imdevimab (Ronapreve)
o Nirmatrelvir and Ritonavir (Paxlovid)
o Remdesivir (Veklury)
o Tocilizumab (Actemra)
Last modified:
